Home › News and Press › Press releases

News and Press releases

View all News Press releases

Bulletin from the Extraordinary General Meeting of Oxcia AB on 24 September 2026

September 24, 2026 · Press releases

Awareness Month for Pulmonary Fibrosis

September 23, 2026 · News

OXC-201 also granted ODD by the FDA

September 15, 2026 · Press releases

OXC-201 has secured Orphan Drug Designation from European Medicines Agency

August 27, 2026 · Press releases

Oxcia AB (publ) publishes interim report for the second quarter 2026

August 25, 2026 · Press releases

Oxcia Appoints Dr. Sandra Ekstedt as New Preclinical Director

July 22, 2026 · Press releases

Oxcia AB Publishes Annual Report for 2025

May 25, 2026 · Press releases

Notice of General Meeting

May 20, 2026 · Press releases

Patent approval for OXC-201 now also secured in Canada

May 12, 2026 · Press releases

Patent approval for OXC-201 now also secured in Canada

· Press releases

OXC-101 for AML accepted to be presented at EHA

April 30, 2026 · Press releases

Oxcia AB (publ) publishes interim report for the first quarter 2026

April 22, 2026 · Press releases

Search